BMS Broadens Market, De-Risks Long-Term Revenue Potential For Reblozyl

FDA Approves Drug’s Third US Indication And Its Biggest Yet

 
• By Mandy Jackson
man showing plaster after donation blood, blood transfusion
Reblozyl is approved in the first line for transfusion-dependent anemia in MDS • Source: Shutterstock

More from New Products

More from Scrip